Gary is a recognized leader in global health, having decades of experience working across sectors - business, government, national and international health agencies, and NGOs - leading to a deep understanding of what needs to be done to tackle and address at scale some of the world's most challenging unmet health needs.  He previously served as a United Nations Commissioner on Life-Saving Commodities for Women and Children, as a board director of UNICEF USA, as chair of the US Centers for Disease Control and Prevention (CDC) Foundation, and as chair of the CDC Corporate Roundtable on Global Health Threats.  He is also the founder and board chair of Together for Girls, a global nonprofit partnership to stop violence against children, particularly sexual violence against girls, presently active in 25 countries.  Gary’s leadership of MNHI followed a very successful 37-year career at BD, including 25 years as an executive officer, over which time he had led all of BD’s medical device businesses and all international operations of the company.  During his last decade at BD, Gary focused specifically on addressing major unmet global health needs, particularly in circumstances where vulnerable, low-resource populations experienced substantial health burdens.

Rochelle was the Vice President of Audit and Enterprise Risk Management at Becton Dickinson (BD).  Rochelle joined BD in July 2015 as Senior Vice President and Chief Financial Officer, BD Life Sciences, and in 2016, she helped establish the BD Foundation and became its Treasurer and a member of its Board of Trustees. Rochelle has held various positions responsible for the management of financial functions involving accounting and financial reporting, investor relations, corporate finance, risk management and treasury.

Mario was formerly with the World Health Organization's Division of Reproductive Health.  Mario 
is an obstetrician-gynecologist with extensive expertise in global health research and in medical affairs within industry settings, including fostering and developing innovative technology, designing and implementing clinical evidence generation plans, conducting systematic literature reviews and risk management activities and assuring compliance with good clinical practices and safety policies and procedures.

Shirley has over 20 years of extensive medical device experience. She has held positions of increasing responsibility in both multinational corporations and dynamic start-ups such as BD, Medtronic and Aerin Medical. She has a proven track record of building and leading high-performing quality and regulatory teams to support the full lifecycle of medical devices from design concept to production and post-commercial launch activities.

Charlie serves as Vice President Europe, bringing over 17 years of experience spanning from global medical technology giants to innovative startups within the medical device sector, including her former role as BD Business Development Executive, UK. She is an accomplished leader in global business development, market shaping, and sales management, with a proven track record of guiding cross-functional teams to successfully launch cutting-edge medical devices, from concept through to commercialization.

Elliott leads MNHI’s legal and compliance function, bringing more than 25 years of experience as a business-focused commercial and corporate lawyer across Europe and the United States.  Prior to joining MNHI in 2022, he held a succession of senior roles at BD, including responsibility for regional legal support across southern Europe and as general counsel for three worldwide business units.  Before joining the medical device industry in 2004, Elliott was an attorney in the New York and Paris offices of the law firm Willkie Farr & Gallagher.